PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Japan Urges Pfizer Chief To Accelerate Vaccine Delivery Amid Omicron Threat

12/16/2021 | 11:38pm EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASAHI GROUP HOLDINGS, LTD. -0.12% 4227 Delayed Quote.-5.34%
NIKKEI 225 -0.94% 26748.14 Real-time Quote.-6.22%
PFIZER, INC. 1.00% 53.41 Delayed Quote.-9.55%
TV ASAHI HOLDINGS CORPORATION -0.90% 1439 Delayed Quote.2.72%
All news about PFIZER, INC.
05/24GLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
05/24WALL STREET STOCK EXCHANGE : Snap cut the rally short
05/24MarketScreener's World Press Review : May 24, 2022
05/24Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-..
BU
05/24Pfizer Sees Positive Results in Etrasimod Trials
DJ
05/24China's bet on homegrown mRNA vaccines holds back nation
AQ
05/23Pfizer says 3 COVID shots protect children under 5
AQ
05/23Wall Street rebounds with assist from banks, big tech
RE
05/23What's next for COVID-19 vaccines for youngest US children
AQ
05/23GLOBAL MARKETS LIVE : Tesla, Kohl's, Apple, JPMorgan, Bank of America...
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 662 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,91x
Yield 2022 3,04%
Capitalization 300 B 300 B -
EV / Sales 2022 2,78x
EV / Sales 2023 3,62x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 53,41 $
Average target price 57,66 $
Spread / Average Target 7,96%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-9.55%296 704
JOHNSON & JOHNSON6.04%472 179
ROCHE HOLDING AG-14.40%273 052
ELI LILLY AND COMPANY10.77%272 388
ABBVIE INC.10.13%261 585
NOVO NORDISK A/S2.29%245 087